Raccoon Poxvirus as a Mucosal Vaccine Vector for Domestic Cats

References

• Beaud, G. (1995) “Vaccinia virus DNA replication: a short review”, Biochimie 77, 774–779.
   PubMed Web of Science ®Google Scholar
• Buller, R.M., Smith, G.L., Cremer, K., Notkins, A.L. and Moss, B. (1985) “Decreased virulence of recombinant vaccine virus expression vectors is associated with a thymidine kinase-negative phenotype”, Nature 317, 813–815.
   PubMed Web of Science ®Google Scholar
• Carroll, M.W. and Moss, B. (1997) “Poxviruses as expression vectors”, Curr. Opin. Biotechnol. 8, 573–577.
   PubMed Web of Science ®Google Scholar
• Cocker, F.M., Gaskell, R.M., Newby, T.J., Gaskell, C.J., Stokes, C.R. and Bourne, F.J. (1984) “Efficacy of early (48 and 96 hour) protection against feline viral rhinotracheitis following intranasal vaccination with a live temperature sensitive mutant”, Vet. Rec. 114, 353–354.
   Google Scholar
• Cocker, F.M., Newby, T.J., Gaskell, R.M., Evans, P.A., Gaskell, C.J., Stokes, C.R., Harbour, D.A. and Bourne, J.F. (1986) “Responses of cats to nasal vaccination with a live, modified feline herpesvirus type 1”, Res. Vet. Sci. 41, 323–330.
   PubMed Web of Science ®Google Scholar
• DeMartini, J.C., Bickle, H.M., Brodie, S.J., He, B.X. and Esposito, J.J. (1993) “Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheep”, Arch. Virol., 133.
   Google Scholar
• Ellner, P.D. (1998) “Smallpox: gone but not forgotten”, Infection 26, 263–269.
   PubMed Web of Science ®Google Scholar
• Esplin, D.G., McGill, L.D., Meininger, A.C. and Wilson, S.R. (1993) “Postvaccination sarcomas in cats”, J. Am. Vet. Med. Assoc. 202, 1245–1247.
   PubMed Web of Science ®Google Scholar
• Esposito, J.J., Knight, J.C., Shaddock, J.H., November, F.J. and Baer, G.M. (1988) “Successful oral rabies vaccination of raccoons with raccoon poxviurs recombinants expressing rabies virus glyco- protein”, Virology 165, 313–316.
   PubMed Web of Science ®Google Scholar
• Esposito, J.J., Chandler, F.W. and Baer, G.M. (1989) “Oral immunization of animals with raccoon poxvirus expressing rabies virus glycoprotein”, Vaccines 89 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY), pp 403–408.
   Google Scholar
• Fekadu, M., Shaddock, J.H., Sumner, J.W., Sanderlin, D.W., Knight, J.C., Esposito, J.J. and Baer, G.M. (1991) “Oral vaccination of skunks with raccoon poxvirus recombinants expressing the rabies glycoprotein or the nucleoprotein”, J. Wildl. Dis. 27, 681–684.
   Google Scholar
• Fenner, F. (1979) “Portraits of viruses: the poxviruses”, Intervirology 11, 137–157.
   PubMed Web of Science ®Google Scholar
• Flexner, C. and Moss, B. (1997) “New generation vaccines”, In: Levine, M.M., Woodrow, G.C., Kasper, J.B. and Cobon, G.S., eds, New Generation Vaccines (Marcel Dekker, New York), pp 297–314.
   Google Scholar
• Girard, M., Habel, A. and Chanel, C. (1999) “New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview”, C R Acad. Sci. III 322, 959–966.
   PubMed Web of Science ®Google Scholar
• Hekker, A.C., Bos, J.M. and Smith, L. (1973) “A stable freeze-dried smallpox vaccine made in monolayer cultures of primary rabbit kidney cells”, J. Biol. Stand. 1, 21–32.
   Google Scholar
• Hendrick, M.J., Kass, P.H., McGill, L.D. and Tizard, I.R. (1994) “Postvaccinal sarcomas in cats”, J. Natl Cancer Inst. 86, 341–343.
   Google Scholar
• Herman, Y.F. (1964) “Isolation and characterization of a naturally occurring poxvirus of raccoons”, Bacteriol. Proc. 64th Annu. Meeting Am. Soc. Microbiol., 117.
   Google Scholar
• Hou, Y., Hu, W.G., Hirano, T. and Gu, X.X. (2002) “A new intra- NALT route elicits mucosal and systemic immunity against Moraxella catarrhalis in a mouse challenge model”, Vaccine 20, 2375–2381.
   PubMed Web of Science ®Google Scholar
• Hu, L., Esposito, J.J. and Scott, F.W. (1996) “Raccoon poxvirus feline panleukopenia virus FP2 recombinant protects cats against FPV challenge”, Virology 218, 248–252.
   PubMed Web of Science ®Google Scholar
• Hu, L., Ngichabe, C., Trimarchi, C.V., Esposito, J.J. and Scott, F.W. (1997) “Raccoon poxvirus live recombinant feline panleukopenia virus VP2 and rabies virus glycoprotein bivalent vaccine”, Virology 15, 1466–1472.
   Google Scholar
• Kunisawa, J., Sakaue, G. and Kiyono, H. (2000) “NALT immune system for the development of AIDS mucosal vaccine”, Nihon Rinsho Meneki Gakkai Kaishi 23, 579–581.
   PubMedGoogle Scholar
• Lofquist, J.M., Weimert, N.A. and Hayney, M.S. (2003) “Smallpox: a review of clinical disease and vaccination”, Am. J. Health Syst. Pharm. 60, 749-756, quiz 757–748.
   Google Scholar
• Mackett, M., Smith, G.L. and Moss, B. (1992) “Vaccinia virus: a selectable eukaryotic cloning and expression vector. 1982”, Biotechnology 24, 495–499.
   PubMedGoogle Scholar
• Nakano, J.H. and Esposito, J.J. (1989) “Poxviruses”, In: Scmidt, N.J. and Emmons, R.W., eds, Diagnostic Procedures for Viral, Rickettsial, and Chlamydial Infections (American Public Health Association, Washington, DC), p 224.
   Google Scholar
• Niemialtowski, M.G., Toka, F.N., Malicka, E., Gierynska M., Spohr de Faundez, I. and Schollenberger, A. (1996) “Controlling orthopoxvirus infections—200 years after Jenner’s revolutionary immunization”, Arch. Immunol. Ther. Exp. (Warsz) 44, 373–378.
   Google Scholar
• Osorio, J.E., Powell, T.D., Frank, R.S., Moss, K., Haanes, E.J., Smith, S.R., Rocke, T.E. and Stinchcomb, D.T. (2003) “Recombinant raccoon pox vaccine protects mice against lethal plague”, Vaccine 21, 1232–1238.
   Google Scholar
• Paoletti, E. (1996) “Applications of pox virus vectors to vaccination: an update”, Proc. Natl Acad. Sci. USA 93, 11349–11353.
   PubMed Web of Science ®Google Scholar
• Pincus, S., Tartaglia, J. and Paoletti, E. (1995) “Poxvirus-based vectors as vaccine candidates”, Biologicals 23, 159–164.
   PubMed Web of Science ®Google Scholar
• Rosner, B. (1995) Fundamentals of Biostatistics, 4th Ed. (Duxbury Press, Belmnont, CA). Smith, J.S., Yager, P.A. and Baer, G.M. (1996) “A rapid fluorescent focus inhibition test (RIFFT) for determining rabies virus-neutralizing antibody”, In: Meslin, F., Kaplan, M.M. and Koprowski, H., eds, Laboratory Techniques in Rabies (World Health Organization, Geneva), pp 181–189.
   Google Scholar
• Taylor, J. and Paoletti, E. (1988) “Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines”, Prog. Vet. Microbiol. Immunol. 4, 197–217.
   PubMedGoogle Scholar
• Velge-Roussel, F., Marcelo, P., Lepage, A.C., Buzoni-Gatel, D. and Bout, D.T. (2000) “Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments”, Infect. Immun. 68, 969–972.
   Google Scholar
• Wasmoen, T.L., Kadakia, N.P., Unfer, R.C., Fickbohm, B.L., Cook, C.P., Chu, H.J. and Acree, W.M. (1995) “Protection of cats from infectious peritonitis by vacciniation with a recombinant raccoon poxvirus expressing the nucleocapsid gene of feline infectious peritonitis virus”, Adv. Exp. Med. Biol. 380, 221–228.
   Google Scholar
• Weiss, D.J., Liggitt, D. and Clark, J.G. (1997) “In situ histochemical detection of beta-galactosidase activity in lung: assessment of X-Gal reagent in distinguishing lacZ gene expression and endogenous beta- galactosidase activity”, Hum. Gene. Ther. 8, 1545–1554.
   Web of Science ®Google Scholar
• Wu, H.Y. and Russell, M.W. (1997) “Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system”, Immunol. Res. 16, 187–201.
   Google Scholar
• Yanagita, M., Hiroi, T., Kitagaki, N., Hamada, S., Ito, H.O., Shimauchi, H., Murakami, S., Okada, H. and Kiyono, H. (1999) “Nasophar- yngeal-associated lymphoreticular tissue (NALT) immunity: fim-briae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production”, J. Immunol. 162, 3559–3565.
   Web of Science ®Google Scholar